|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/415 | |
| C07D 231/38 | |||
| A61P 29/00 |
| (11) | Patento numeris | 3484471 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17742278.9 |
| Europos patento paraiškos padavimo data | 2017-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/052056 |
| Data | 2017-07-13 |
| (87) | Numeris | WO 2018/011579 |
| Data | 2018-01-18 |
| (30) | Numeris | Data | Šalis |
| 201612240 | 2016-07-14 | GB |
| (72) |
SULEIMAN, Osama, GB
PEREZ, Lucia Romero, GB
HARLACHER, Cornelius Stephan, CH
JONES, Stewart, GB
|
| (73) |
Mereo BioPharma 1 Limited,
1 Cavendish Place, London, Greater London W1G 0QF,
GB
|
| (54) | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
| METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |